Showing 41-50 of 8577 results for "".
Skin Cancer Prevention: Can Laser Therapy Help?
https://practicaldermatology.com/conferences/scale-2023/skin-cancer-prevention-can-laser-therapy-help/20205/Non-ablative fractional laser treatments may dramatically the reduce risk of skin cancer recurrence. Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss the science behind this intriguing finding.First, Do No Harm
https://practicaldermatology.com/conferences/scale-2023/first-do-no-harm/20206/Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss why dermatologists should report any side effects to the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database.Skin-boosting: The New Frontier in Injectable Beauty
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/skin-boosting-the-new-frontier-in-injectable-beauty/19776/Dermatologists are increasingly using soft tissue fillers to hydrate the skin, explains Jeanette M. Black, M.D. By injecting certain hyaluronic acid fillers intradermally, it’s possible to increase hydration and glow, she says.Advances in Devices for Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-devices-for-dermatology/18815/M. Christine Lee, MD provides an overview of some of the new and emerging laser technologies. She discusses advances in everything from lasers and light-based devices to radiofrequency, ultrasound, and combination devices for a variety of dermatologic issues including facial rejuvenation, vaginal reHidradenitis Suppurativa: Seeking More Pieces to the Puzzle
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-seeking-more-pieces-to-the-puzzle/23669/Evidence suggests that integrated approaches to care may yield best results for many patients.Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuQuestions on Established Patients, Medicare Services for Families, and Coding for Destructions
https://practicaldermatology.com/topics/practice-management/questions-on-established-patients-medicare-services-for-families-and-coding-for-destructions/21667/Seeing new patients doesn't necessarily provide better reimbursement than Established Patients. Here are answers to questions on this and other coding matters.Top 5 Skincare Trends on Social Media: What is Truly “Verified?”
https://practicaldermatology.com/issues/june-2024/top-5-skincare-trends-on-social-media-what-is-truly-verified/26556/Top 5 Skincare Trends on Social Media: What is Truly “Verified?”Revisiting Cyclosporine in the Age of Biologics: Update on Efficacy and Mechanism of Action
https://practicaldermatology.com/topics/general-topics/revisiting-cyclosporine-in-the-age-of-biologics-update-on-efficacy-and-mechanism-of-action/21937/Increased understanding of the immunologic basis of psoriasis supports the role of cyclosporine in patient management.The Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.